CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
ELISA assessment of apoptosis markers in gingival crevicular fluidother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04984031
NCT04984031N/ACompleted

Assessment of Apoptosis Markers Caspase-3, Caspase-8, Caspase-9 and Apoptosis Inducing Factor (AIF) Levels in Generalized Versus Molar-incisor Grade C Periodontitis

Asem Mohammed Kamel Ali·observational·Posted Jul 30, 2021·Updated Sep 19, 2024

In Brief

An observational study evaluating ELISA assessment of apoptosis markers in gingival crevicular fluid for Molar-incisor Pattern Grade C Periodontitis ( Localized Aggressive Periodontitis) and Generalized Grade C Periodontitis (Generalized Aggressive Periodontitis). Completed, enrolled 50 participants across 1 site.

Detailed Summary

The aim of the present trial is to assess the gingival crevicular fluid level of caspase-3 and apoptosis inducing factor (AIF) in Generalized versus Molar-incisor grade C periodontitis. The present study will be carried out on patients selected from those attending on the outpatient clinics of Department of Oral Medicine, Periodontology, Oral Diagnosis and Dental Radiology, Faculty of Dental Medicine, Al-Azhar University, Assiut.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 30, 2021
Enrollment StartAug 5, 2021
Primary CompletionJan 30, 2022
Study CompletionMar 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.9 years ago

Interventions

ELISA assessment of apoptosis markers in gingival crevicular fluidother

Gingival crevicular fluid (GCF) samples will be collected to assess the level of caspase-3,8,9 and apoptosis inducing factor (Aif)